PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma.
Saved in:
| Title: | PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma. |
|---|---|
| Authors: | Heuer S; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany., Burghaus I; Coordination Centre for Clinical Trials (KKS) Heidelberg, 69120, Heidelberg, Germany., Gose M; Coordination Centre for Clinical Trials (KKS) Heidelberg, 69120, Heidelberg, Germany., Kessler T; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany., Sahm F; Department of Neuropathology, University Hospital Heidelberg, INF 224, 69120, Heidelberg, Germany.; CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), Geman Cancer Research Center (DKFZ), Heidelberg, Germany., Vollmuth P; Department of Neuroradiology, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany., Venkataramani V; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Department of Functional Neuroanatomy, Institute for Anatomy and Cell Biology, Heidelberg University, Heidelberg, Germany., Hoffmann D; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany., Schlesner M; German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Biomedical Informatics, Data Mining and Data Analytics, University of Augsburg, Augsburg, Germany., Ratliff M; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Neurosurgery Clinic, University Hospital Mannheim, 68167, Mannheim, Germany., Hopf C; Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, Paul-Wittsack Str. 10, 68163, Mannheim, Germany.; Medical Faculty, Heidelberg University, Heidelberg, Germany.; Mannheim Center for Translational Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany., Herrlinger U; Division of Clinical Neurooncology, Department of Neurology and Centre of Integrated Oncology, University Hospital Bonn, Bonn, Germany., Ricklefs F; Department of Neurosurgery, University Hospital Eppendorf, Martinistr. 52, 20246, Hamburg, Germany., Bendszus M; Department of Neuroradiology, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany., Krieg SM; Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany., Wick A; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany., Wick W; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany., Winkler F; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany. Frank.Winkler@med.uni-heidelberg.de.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. Frank.Winkler@med.uni-heidelberg.de. |
| Source: | BMC cancer [BMC Cancer] 2024 Jan 26; Vol. 24 (1), pp. 135. Date of Electronic Publication: 2024 Jan 26. |
| Publication Type: | Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Equivalence Trial |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38279087 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Heuer+S%22">Heuer S</searchLink>; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Burghaus+I%22">Burghaus I</searchLink>; Coordination Centre for Clinical Trials (KKS) Heidelberg, 69120, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Gose+M%22">Gose M</searchLink>; Coordination Centre for Clinical Trials (KKS) Heidelberg, 69120, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Kessler+T%22">Kessler T</searchLink>; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Sahm+F%22">Sahm F</searchLink>; Department of Neuropathology, University Hospital Heidelberg, INF 224, 69120, Heidelberg, Germany.; CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), Geman Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Vollmuth+P%22">Vollmuth P</searchLink>; Department of Neuroradiology, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Venkataramani+V%22">Venkataramani V</searchLink>; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Department of Functional Neuroanatomy, Institute for Anatomy and Cell Biology, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Hoffmann+D%22">Hoffmann D</searchLink>; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schlesner+M%22">Schlesner M</searchLink>; German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Biomedical Informatics, Data Mining and Data Analytics, University of Augsburg, Augsburg, Germany.<br /><searchLink fieldCode="AU" term="%22Ratliff+M%22">Ratliff M</searchLink>; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Neurosurgery Clinic, University Hospital Mannheim, 68167, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Hopf+C%22">Hopf C</searchLink>; Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, Paul-Wittsack Str. 10, 68163, Mannheim, Germany.; Medical Faculty, Heidelberg University, Heidelberg, Germany.; Mannheim Center for Translational Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Herrlinger+U%22">Herrlinger U</searchLink>; Division of Clinical Neurooncology, Department of Neurology and Centre of Integrated Oncology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Ricklefs+F%22">Ricklefs F</searchLink>; Department of Neurosurgery, University Hospital Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Bendszus+M%22">Bendszus M</searchLink>; Department of Neuroradiology, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Krieg+SM%22">Krieg SM</searchLink>; Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Wick+A%22">Wick A</searchLink>; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Wick+W%22">Wick W</searchLink>; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Winkler+F%22">Winkler F</searchLink>; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany. Frank.Winkler@med.uni-heidelberg.de.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. Frank.Winkler@med.uni-heidelberg.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2024 Jan 26; Vol. 24 (1), pp. 135. <i>Date of Electronic Publication: </i>2024 Jan 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Equivalence Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38279087 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12885-024-11846-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 135 Titles: – TitleFull: PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Heuer S – PersonEntity: Name: NameFull: Burghaus I – PersonEntity: Name: NameFull: Gose M – PersonEntity: Name: NameFull: Kessler T – PersonEntity: Name: NameFull: Sahm F – PersonEntity: Name: NameFull: Vollmuth P – PersonEntity: Name: NameFull: Venkataramani V – PersonEntity: Name: NameFull: Hoffmann D – PersonEntity: Name: NameFull: Schlesner M – PersonEntity: Name: NameFull: Ratliff M – PersonEntity: Name: NameFull: Hopf C – PersonEntity: Name: NameFull: Herrlinger U – PersonEntity: Name: NameFull: Ricklefs F – PersonEntity: Name: NameFull: Bendszus M – PersonEntity: Name: NameFull: Krieg SM – PersonEntity: Name: NameFull: Wick A – PersonEntity: Name: NameFull: Wick W – PersonEntity: Name: NameFull: Winkler F IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 01 Text: 2024 Jan 26 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1471-2407 Numbering: – Type: volume Value: 24 – Type: issue Value: 1 Titles: – TitleFull: BMC cancer Type: main |
| ResultId | 1 |